EA201290957A1 - Пиразол-4-илгетероциклилкарбоксамидные соединения и способы их применения - Google Patents
Пиразол-4-илгетероциклилкарбоксамидные соединения и способы их примененияInfo
- Publication number
- EA201290957A1 EA201290957A1 EA201290957A EA201290957A EA201290957A1 EA 201290957 A1 EA201290957 A1 EA 201290957A1 EA 201290957 A EA201290957 A EA 201290957A EA 201290957 A EA201290957 A EA 201290957A EA 201290957 A1 EA201290957 A1 EA 201290957A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- pyrazol
- methods
- ilheterocyclilkarboxamide
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Пиразол-4-илгетероциклилкарбоксамидные соединения формулы I, включая их стереоизомеры, геометрические изомеры, таутомеры и фармацевтически приемлемые соли, где Х представляет собой тиазолильное, пиколинильное, пиридинильное, пиримидинильное и фторпиридильное кольцо, полезны для ингибирования киназы Pim и для лечения расстройств, таких как рак, опосредованных киназой Pim. Раскрыты способы применения соединений формулы I для in vitro, in situ и in vivo диагностики, предупреждения или лечения таких расстройств в клетках млекопитающих или ассоциированных патологических состояний.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32158810P | 2010-04-07 | 2010-04-07 | |
PCT/EP2011/055300 WO2011124580A1 (en) | 2010-04-07 | 2011-04-06 | Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201290957A1 true EA201290957A1 (ru) | 2013-04-30 |
Family
ID=44227838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201290957A EA201290957A1 (ru) | 2010-04-07 | 2011-04-06 | Пиразол-4-илгетероциклилкарбоксамидные соединения и способы их применения |
Country Status (20)
Country | Link |
---|---|
US (3) | US8436001B2 (ru) |
EP (1) | EP2556066B1 (ru) |
JP (2) | JP6161537B2 (ru) |
KR (1) | KR101464060B1 (ru) |
CN (1) | CN102933572B (ru) |
AU (1) | AU2011237936A1 (ru) |
BR (1) | BR112012025480A2 (ru) |
CA (1) | CA2794801C (ru) |
CL (1) | CL2012002782A1 (ru) |
CO (1) | CO6630133A2 (ru) |
CR (1) | CR20120469A (ru) |
EA (1) | EA201290957A1 (ru) |
ES (1) | ES2601004T3 (ru) |
HK (1) | HK1178149A1 (ru) |
IL (1) | IL222227A0 (ru) |
MA (1) | MA34234B1 (ru) |
MX (1) | MX2012011533A (ru) |
PE (1) | PE20130405A1 (ru) |
SG (1) | SG184475A1 (ru) |
WO (1) | WO2011124580A1 (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2638552C2 (ru) * | 2011-09-27 | 2017-12-14 | Ф. Хоффманн-Ля Рош Аг | Пиразол-4-ил-гетероциклил-карбоксамидные соединения и способы применения |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112014028954A2 (pt) | 2012-05-21 | 2017-07-18 | Novartis Ag | amidas de n-piridinila substituídas no anel como inibidores da quinase |
WO2014033630A1 (en) | 2012-08-31 | 2014-03-06 | Novartis Ag | Novel aminothiazole carboxamides as kinase inhibitors |
WO2014033631A1 (en) | 2012-08-31 | 2014-03-06 | Novartis Ag | N-(3-pyridyl) biarylamides as kinase inhibitors |
SI2900657T1 (sl) * | 2012-09-26 | 2020-07-31 | F. Hoffmann-La Roche Ag | Ciklični eter pirazol-4-il-heterociklil-karboksamidne spojine in načini uporabe |
US20150336960A1 (en) | 2012-12-19 | 2015-11-26 | Novartis Ag | Aryl-substituted fused bicyclic pyridazine compounds |
JP6437452B2 (ja) | 2013-01-14 | 2018-12-12 | インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation | Pimキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物 |
DK2945939T3 (da) | 2013-01-15 | 2020-03-23 | Incyte Holdings Corp | Thiazolcarboxamider og pyridincarboxamidforbindelser anvendelige som pim-kinaseinhibitorer |
AR097431A1 (es) * | 2013-08-23 | 2016-03-16 | Incyte Corp | Compuestos de carboxamida de furo y tienopiridina útiles como inhibidores de quinasas pim |
NZ631142A (en) * | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
WO2015068856A1 (en) * | 2013-11-08 | 2015-05-14 | Takeda Pharmaceutical Company Limited | Pyrazole for the treatment autoimmune disorders |
MX2016012007A (es) * | 2014-03-18 | 2016-12-05 | Hoffmann La Roche | Compuestos de oxepan-2-il-pirazol-4-il-heterociclil-carboxamida y metodos de uso. |
US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
WO2016010897A1 (en) | 2014-07-14 | 2016-01-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors |
WO2016123627A1 (en) * | 2015-01-30 | 2016-08-04 | Vanderbilt University | Isoquiniline and napthalene-substituted compounds as mglur4 allosteric potentiators, compounds, and methods of treating neurological dysfunction |
SI3286181T1 (sl) * | 2015-04-22 | 2021-07-30 | Rigel Pharmaceuticals, Inc. | Spojine pirazola in postopek izdelave in uporabe spojin |
WO2016196244A1 (en) | 2015-05-29 | 2016-12-08 | Incyte Corporation | Pyridineamine compounds useful as pim kinase inhibitors |
AR105967A1 (es) | 2015-09-09 | 2017-11-29 | Incyte Corp | Sales de un inhibidor de pim quinasa |
CN105254624B (zh) * | 2015-09-18 | 2019-08-09 | 上海吉铠医药科技有限公司 | 异噻唑衍生物pim激酶抑制剂及其制备方法与在制药中的应用 |
US9920032B2 (en) | 2015-10-02 | 2018-03-20 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
EP4212523A1 (en) * | 2016-10-26 | 2023-07-19 | Rigel Pharmaceuticals, Inc. | Pyrazole amide compounds as irak inhibitors |
EP3706735A1 (en) | 2017-11-06 | 2020-09-16 | Snap Bio, Inc. | Pim kinase inhibitor compositions, methods, and uses thereof |
US10596161B2 (en) | 2017-12-08 | 2020-03-24 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
SG11202008560VA (en) | 2018-03-08 | 2020-10-29 | Incyte Corp | AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
CN110452180A (zh) * | 2019-06-25 | 2019-11-15 | 南京普锐达医药科技有限公司 | 一种合成2-氯-5-氨基-6-嘧啶甲酸乙酯的方法 |
MX2022002292A (es) | 2019-08-30 | 2022-06-02 | Rigel Pharmaceuticals Inc | Compuestos de pirazol, formulaciones de los mismos y un metodo para usar los compuestos y/o formulaciones. |
CN111087389B (zh) * | 2019-12-03 | 2020-10-27 | 佳木斯大学 | 一种用于治疗胶质母细胞瘤的药物 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US5543523A (en) | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
US8828902B2 (en) | 2001-07-12 | 2014-09-09 | Reaxa Limited | Microencapsulated catalyst methods of preparation and method of use thereof |
ES2350837T3 (es) * | 2003-05-01 | 2011-01-27 | Bristol-Myers Squibb Company | Compuestos de pirazol-amida sustituidos con arilo útiles como inhibidores de quinasas. |
KR20070049655A (ko) * | 2004-08-13 | 2007-05-11 | 제넨테크, 인크. | Atp-이용 효소 억제 활성을 나타내는2-아미도-티아졸-기재 화합물과 조성물 및 이들의 용도 |
WO2008007113A2 (en) | 2006-07-14 | 2008-01-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
CA3052368A1 (en) | 2005-10-07 | 2007-04-19 | Exelixis, Inc. | Azetidines as mek inhibitors |
EP1968579A1 (en) | 2005-12-30 | 2008-09-17 | Astex Therapeutics Limited | Pharmaceutical compounds |
UY30183A1 (es) | 2006-03-02 | 2007-10-31 | Astrazeneca Ab | Derivados de quinolina |
TW200801513A (en) | 2006-06-29 | 2008-01-01 | Fermiscan Australia Pty Ltd | Improved process |
FR2903406B1 (fr) | 2006-07-04 | 2012-08-10 | Aventis Pharma Sa | Derives de pyrazolylbenzimidazole,compositions les contenant et utilisation |
JP2009543770A (ja) | 2006-07-14 | 2009-12-10 | アステックス・セラピューティクス・リミテッド | Cdk及びgskの阻害のためのピラゾール誘導体の組合せ剤 |
US20090318430A1 (en) | 2006-07-21 | 2009-12-24 | Astex Therapeutics Limited | Medical use of cyclin dependent kinases inhibitors |
KR20090082440A (ko) | 2006-10-31 | 2009-07-30 | 쉐링 코포레이션 | 단백질 키나제 억제제로서의 2-아미노티아졸-4-카복실산 아미드 |
MX2009004786A (es) | 2006-10-31 | 2009-06-05 | Schering Corp | Derivados de anilinopiperazina y sus metodos de uso. |
GB0701426D0 (en) | 2007-01-25 | 2007-03-07 | Univ Sheffield | Compounds and their use |
CN101679266B (zh) * | 2007-03-01 | 2015-05-06 | 诺华股份有限公司 | Pim激酶抑制剂及其应用方法 |
US8333102B2 (en) * | 2007-06-22 | 2012-12-18 | Adam Van Opynen | Extension for a pipe expander |
AR067585A1 (es) * | 2007-07-19 | 2009-10-14 | Schering Corp | Compuestos heterociclicos de amidas como inhibidores de la proteincinasa |
WO2009054468A1 (ja) | 2007-10-24 | 2009-04-30 | Astellas Pharma Inc. | アゾールカルボキサミド化合物又はその塩 |
MX2010004876A (es) * | 2007-10-29 | 2010-07-28 | Schering Corp | Derivados de diamido tiazol como inhibidores de la proteina cinasa. |
JP5230035B2 (ja) * | 2007-10-29 | 2013-07-10 | メルク・シャープ・アンド・ドーム・コーポレーション | プロテインキナーゼ阻害剤としてのチアゾール誘導体 |
EP2209779A1 (en) * | 2007-10-29 | 2010-07-28 | Schering Corporation | Heterocyclic urea and thiourea derivatives and methods of use thereof |
EP2070916A1 (de) | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | 2-Aryl-thiazol-4-carbonsäureamid-Derivate, deren Herstellung und Verwendung als Arzneimittel |
EP2070924A1 (de) | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | Neue 2-Hetarylthiazol-4-carbonsäureamid-Derivative, deren Herstellung und Verwendung als Arzneimittel |
AR069650A1 (es) | 2007-12-14 | 2010-02-10 | Actelion Pharmaceuticals Ltd | Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano |
US8916591B2 (en) | 2008-01-22 | 2014-12-23 | Vernalis (R&D) Ltd | Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity |
AR070531A1 (es) * | 2008-03-03 | 2010-04-14 | Novartis Ag | Inhibidores de cinasa pim y metodos para su uso |
US20110118236A1 (en) * | 2008-03-25 | 2011-05-19 | Michiyo Mochizuki | Heterocyclic compound |
HUE026381T2 (en) * | 2008-09-02 | 2016-06-28 | Novartis Ag | Kinase inhibitor picolinamide derivatives |
WO2011000020A1 (en) | 2009-06-12 | 2011-01-06 | Sbc Research Pty Ltd | Enhanced method of detection |
UA110324C2 (en) | 2009-07-02 | 2015-12-25 | Genentech Inc | Jak inhibitory compounds based on pyrazolo pyrimidine |
SG10201405568UA (en) * | 2009-09-08 | 2014-11-27 | Hoffmann La Roche | 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
BR112012009574A2 (pt) | 2009-10-22 | 2019-09-24 | Univ Vanderbilt | potencializador alostérico de mglura, composições, e métodos de tratamento de disfunção neurológica |
US8470820B2 (en) | 2010-01-22 | 2013-06-25 | Hoffman-La Roche Inc. | Nitrogen-containing heteroaryl derivatives |
US8703768B2 (en) | 2010-06-09 | 2014-04-22 | Hoffmann-La Roche Inc. | Nitrogen containing heteroaryl compounds |
-
2011
- 2011-04-06 BR BR112012025480-4A patent/BR112012025480A2/pt not_active IP Right Cessation
- 2011-04-06 ES ES11713749.7T patent/ES2601004T3/es active Active
- 2011-04-06 EA EA201290957A patent/EA201290957A1/ru unknown
- 2011-04-06 JP JP2013503090A patent/JP6161537B2/ja not_active Expired - Fee Related
- 2011-04-06 PE PE2012001997A patent/PE20130405A1/es not_active Application Discontinuation
- 2011-04-06 MA MA35372A patent/MA34234B1/fr unknown
- 2011-04-06 SG SG2012074324A patent/SG184475A1/en unknown
- 2011-04-06 US US13/080,762 patent/US8436001B2/en not_active Expired - Fee Related
- 2011-04-06 MX MX2012011533A patent/MX2012011533A/es active IP Right Grant
- 2011-04-06 CA CA2794801A patent/CA2794801C/en not_active Expired - Fee Related
- 2011-04-06 AU AU2011237936A patent/AU2011237936A1/en not_active Abandoned
- 2011-04-06 EP EP11713749.7A patent/EP2556066B1/en not_active Not-in-force
- 2011-04-06 WO PCT/EP2011/055300 patent/WO2011124580A1/en active Application Filing
- 2011-04-06 KR KR1020127029089A patent/KR101464060B1/ko active IP Right Grant
- 2011-04-06 CN CN201180028158.4A patent/CN102933572B/zh not_active Expired - Fee Related
-
2012
- 2012-09-17 CR CR20120469A patent/CR20120469A/es unknown
- 2012-09-27 IL IL222227A patent/IL222227A0/en unknown
- 2012-10-04 CL CL2012002782A patent/CL2012002782A1/es unknown
- 2012-10-09 CO CO12177921A patent/CO6630133A2/es not_active Application Discontinuation
-
2013
- 2013-03-15 US US13/834,316 patent/US8669361B2/en not_active Expired - Fee Related
- 2013-04-26 HK HK13105060.9A patent/HK1178149A1/xx not_active IP Right Cessation
-
2014
- 2014-01-13 US US14/153,891 patent/US9573943B2/en not_active Expired - Fee Related
-
2015
- 2015-09-28 JP JP2015189690A patent/JP2016040281A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2638552C2 (ru) * | 2011-09-27 | 2017-12-14 | Ф. Хоффманн-Ля Рош Аг | Пиразол-4-ил-гетероциклил-карбоксамидные соединения и способы применения |
Also Published As
Publication number | Publication date |
---|---|
MX2012011533A (es) | 2012-12-17 |
EP2556066B1 (en) | 2016-10-19 |
CN102933572A (zh) | 2013-02-13 |
US8669361B2 (en) | 2014-03-11 |
JP2013523798A (ja) | 2013-06-17 |
CN102933572B (zh) | 2015-01-07 |
CR20120469A (es) | 2012-11-30 |
US20130203732A1 (en) | 2013-08-08 |
CL2012002782A1 (es) | 2013-01-18 |
WO2011124580A1 (en) | 2011-10-13 |
US20140128376A1 (en) | 2014-05-08 |
PE20130405A1 (es) | 2013-04-10 |
HK1178149A1 (en) | 2013-09-06 |
AU2011237936A1 (en) | 2012-10-11 |
CO6630133A2 (es) | 2013-03-01 |
BR112012025480A2 (pt) | 2020-08-18 |
IL222227A0 (en) | 2012-12-31 |
JP2016040281A (ja) | 2016-03-24 |
ES2601004T3 (es) | 2017-02-13 |
US8436001B2 (en) | 2013-05-07 |
KR20130001309A (ko) | 2013-01-03 |
CA2794801C (en) | 2019-01-15 |
CA2794801A1 (en) | 2011-10-13 |
US20110251176A1 (en) | 2011-10-13 |
US9573943B2 (en) | 2017-02-21 |
KR101464060B1 (ko) | 2014-11-20 |
MA34234B1 (fr) | 2013-05-02 |
SG184475A1 (en) | 2012-11-29 |
EP2556066A1 (en) | 2013-02-13 |
JP6161537B2 (ja) | 2017-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201290957A1 (ru) | Пиразол-4-илгетероциклилкарбоксамидные соединения и способы их применения | |
EA201590624A1 (ru) | Циклические эфиры пиразол-4-ил-гетероциклил-карбоксамидных соединений и способы их применения | |
MX2014014828A (es) | Compuestos de 5-azaindazol y metodos de uso. | |
MX361807B (es) | Compuestos de heteroaril piridona y aza-piridona. | |
MY160349A (en) | Pyridone and aza-pyridone compounds and methods of use | |
MX2014005282A (es) | Compuestos de 8-fluoroftalazin-1 (2h) -ona. | |
MX2014005285A (es) | Compuestos biciclicos de piperazina. | |
MX2014001239A (es) | Compuestos de pirazolo [3,4-c] piridina y metodos de uso. | |
MX2014005289A (es) | Compuestos de piperazina alquilados. | |
EA201390879A1 (ru) | Трициклические ингибиторы pi3k и способы их применения | |
MX2016007171A (es) | Compuestos de heteroaril piridona y azapiridona con funcionalidad electrofila. | |
PH12014501947A1 (en) | Serine/threonine kinase inhibitors | |
MX340013B (es) | Compuestos de benzoxazepina selectivos para fosfatidilinositol 3-cinasa (pi3k) p110 delta y metodos de uso. | |
UA111933C2 (uk) | Піролопіридини як інгібітори кінази | |
MA32272B1 (fr) | Inhibiteurs de raf de pyrazole [3,4-b]pyridine | |
MX2015018038A (es) | Compuestos de heteroaril-piridona y aza-piridona-amida. | |
MX2011012520A (es) | Compuestos inhibidores de pi3k de pirimidina biciclicos selectivos para p110 delta y metodos de uso de los mismos. | |
MX2016008449A (es) | Inhibidores de serina/treonina cinasa. | |
SG178899A1 (en) | Raf inhibitor compounds and methods of use thereof | |
MX2011011083A (es) | Compuestos heterociclicos como inhibidores de mek. | |
SG178900A1 (en) | Raf inhibitor compounds and methods of use thereof | |
MX2016012007A (es) | Compuestos de oxepan-2-il-pirazol-4-il-heterociclil-carboxamida y metodos de uso. | |
MX2017000544A (es) | Compuestos de quinoxalina, metodo para preparar los mismos y uso de los mismos. | |
NZ620928A (en) | Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | |
MA42864B1 (fr) | Composes d’éther cyclique-pyrazol-4-yl-heterocyclyl-carboxamide et procédés d'utilisation |